Is Indaptus Therapeutics Inc (NASDAQ: INDP) Back In The Buying Zone?
Currently, there are 14.43M common shares owned by the public and among those 11.61M shares have been available to trade. The company’s stock has a 5-day price change of -3.57% and -19.80% over the past three months. INDP shares are trading -3.81% year to date (YTD), with the 12-month market performance down to -57.59% lower. […]
